Weight Loss and Obesity Management Market – Market Insights

Obesity is defined as excess body fat accumulation. The major factors contributing to obesity throughout the world are diseases and adoption of unhealthy lifestyle. Different methods used for management of weight loss and obesity are drugs, dietary supplements, weight loss surgery (bariatric surgery), and exercising. According to the World Health Organization, when the Body-Mass-Index is greater than or equal to 25, the person is categorized as overweight; and BMI index above 30 is classified as obese.

The global weight loss and obesity management market is estimated to be valued at US$ 170.0 billion in 2019, and is expected to exhibit a CAGR of 7.1% over the forecast period (2019-2027).

Figure 1. Global Weight Loss and Obesity Management Market Value (US$ Mn), by Region, 2019

Weight Loss and Obesity Management  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2020)

Increasing prevalence of obesity is expected to propel the market growth

Increasing prevalence of obesity in developed and emerging economies of the world is projected to propel the growth of the market during the forecasted period. For instance, according to reports published by the World Federation of Obesity, roughly 27.4 million children in India will be obese by 2030. This rapid increase in childhood obesity in India is expected to increase demand for weight loss and obesity management techniques during the forecast period.

Furthermore, increasing research and development, and adoption of strategies such as collaborations and development of novel products by market players to expand their geographical footprint is expected to drive growth of the weight loss and obesity management market. For instance, in July 2018, Eisai Co., Ltd. entered an agreement to grant exclusive development and marketing rights to CY Biotech for its anti-obesity agent lorcaserin hydrochloride (lorcaserin) in China.

Furthermore, factors such as limited awareness in lower income countries and high cost of weight loss and obesity management products & services is expected to hinder the growth of the market during the forecast period.

 Figure 2. Global Weight Loss and Obesity Management Market Share (%), by Age Group Type, (2019-2027)

Weight Loss and Obesity Management  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2020)

Increasing adoption of strategies by major players operating in the market is expected to fuel growth of the weight loss and obesity management market

Manufacturers are focusing on strengthening their market position through strategic mergers, acquisitions, and collaborations. For instance, in October 2018, Eisai Co., Ltd. entered an agreement with Eurofarma Laboratories S.A. to grant exclusive development and marketing rights for its anti-obesity agent, lorcaserin hydrochloride, in 17 countries in Latin America and the Caribbean, excluding Brazil.

Key Players

Major players operating in the global weight loss and obesity management market include Novo Nordisk A/S, Takeda Pharmaceutical Company Ltd, Eisai Co., Ltd., F. Hoffmann-La Roche Ltd, VIVUS Inc., Herbalife Ltd., Apollo Endosurgery (U.S.), Amer Sports, Brunswick Corporation, Cybex International, Duke Products & Services & Fitness Center, Ethicon Inc., Equinox, Inc., Johnson & Johnson Services, Inc., Kellogg Company, Life Time Fitness Inc., Medtronic, and NutriSystem, Inc.

Obesity refers to body fat and body mass index above 25 (overweight) and 30 (obese), respectively. It is one of the most prevalent disease conditions across the world. It affects individuals in developed, emerging, and undeveloped regions. The weight loss and obesity management services involve the use of certain products such as dietary supplements, medications, surgical interventions, and fitness equipment. According to the World Health Organization, when the Body-Mass-Index is greater than or equal to 25, the person is categorized as overweight; and BMI index above 30 is classified as obese.

Market Dynamics

Increasing incidence of obesity in developed and developing economies of the world is expected to assist growth of the weight loss and obesity management market during the forecast period. For instance, according to the WHO reports published in 2018, around 35.8 million disabilities worldwide are caused due to obesity. Furthermore, increasing research and development, and adoption of strategies such as collaborations and development of novel products by market players to expand their geographical footprint is expected to drive growth of the weight loss and obesity management market.

Key features of the study:

  • This report provides in-depth analysis of the global weight loss and obesity management market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global weight loss and obesity management market  based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Novo Nordisk A/S, Takeda Pharmaceutical Company Ltd, Eisai Co., Ltd., F. Hoffmann-La Roche Ltd, VIVUS Inc., Herbalife Ltd., Apollo Endosurgery (U.S.), Amer Sports, Brunswick Corporation, Cybex International, Duke Products & Services & Fitness Center, Ethicon Inc., Equinox, Inc., Johnson & Johnson Services, Inc., Kellogg Company, Life Time Fitness Inc., Medtronic, and NutriSystem, Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, technology up gradation, market expansion, and marketing tactics
  • The global weight loss and obesity management market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global weight loss and obesity management market

Detailed Segmentation:

  • Global Weight Loss and Obesity Management Market, By Product & Services:
    • Drugs
      • Bupropion-naltrexone (Contrave)
      • Liraglutide (Saxenda)
      • Lorcaserin (Belviq)
      • Orlistat (Xenical)
      • Phentermine-topiramate (Qsymia)
      • Others
    • Supplements
    • Equipment
      • Fitness Equipment
      • Surgical Equipment
    • Services
      • Consulting Service
      • Online Weight Loss Programs
      • Others
  • Global Weight Loss and Obesity Management Market, By Age Group:
    • Children
    • Adults
    • Geriatrics
  • Global Weight Loss and Obesity Management Market, By Region:
    • North America
      • By Product & Services:
        • Drugs
          • Bupropion-naltrexone (Contrave)
          • Liraglutide (Saxenda)
          • Lorcaserin (Belviq)
          • Orlistat (Xenical)
          • Phentermine-topiramate (Qsymia)
          • Others
        • Supplements
        • Equipment
          • Fitness Equipment
          • Surgical Equipment
        • Services
          • Consulting Service
          • Online Weight Loss Programs
          • Others
      • By Age Group:
        • Children
        • Adults
        • Geriatrics
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product & Services:
        • Drugs
          • Bupropion-naltrexone (Contrave)
          • Liraglutide (Saxenda)
          • Lorcaserin (Belviq)
          • Orlistat (Xenical)
          • Phentermine-topiramate (Qsymia)
          • Others
        • Supplements
        • Equipment
          • Fitness Equipment
          • Surgical Equipment
        • Services
          • Consulting Service
          • Online Weight Loss Programs
          • Others
      • By Age Group:
        • Children
        • Adults
        • Geriatrics
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product & Services:
        • Drugs
          • Bupropion-naltrexone (Contrave)
          • Liraglutide (Saxenda)
          • Lorcaserin (Belviq)
          • Orlistat (Xenical)
          • Phentermine-topiramate (Qsymia)
          • Others
        • Supplements
        • Equipment
          • Fitness Equipment
          • Surgical Equipment
        • Services
          • Consulting Service
          • Online Weight Loss Programs
          • Others
      • By Age Group:
        • Children
        • Adults
        • Geriatrics
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product & Services:
        • Drugs
          • Bupropion-naltrexone (Contrave)
          • Liraglutide (Saxenda)
          • Lorcaserin (Belviq)
          • Orlistat (Xenical)
          • Phentermine-topiramate (Qsymia)
          • Others
        • Supplements
        • Equipment
          • Fitness Equipment
          • Surgical Equipment
        • Services
          • Consulting Service
          • Online Weight Loss Programs
          • Others
      • By Age Group:
        • Children
        • Adults
        • Geriatrics
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product & Services:
        • Drugs
          • Bupropion-naltrexone (Contrave)
          • Liraglutide (Saxenda)
          • Lorcaserin (Belviq)
          • Orlistat (Xenical)
          • Phentermine-topiramate (Qsymia)
          • Others
        • Supplements
        • Equipment
          • Fitness Equipment
          • Surgical Equipment
        • Services
          • Consulting Service
          • Online Weight Loss Programs
          • Others
      • By Age Group:
        • Children
        • Adults
        • Geriatrics
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product & Services:
        • Drugs
          • Bupropion-naltrexone (Contrave)
          • Liraglutide (Saxenda)
          • Lorcaserin (Belviq)
          • Orlistat (Xenical)
          • Phentermine-topiramate (Qsymia)
          • Others
        • Supplements
        • Equipment
          • Fitness Equipment
          • Surgical Equipment
        • Services
          • Consulting Service
          • Online Weight Loss Programs
          • Others
      • By Age Group:
        • Children
        • Adults
        • Geriatrics
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Novo Nordisk A/S *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Takeda Pharmaceutical Company Ltd
    • Eisai Co., Ltd.
    • Hoffmann-La Roche Ltd
    • VIVUS Inc.
    • Herbalife Ltd.
    • Apollo Endosurgery (U.S.)
    • Amer Sports
    • Brunswick Corporation
    • Cybex International
    • Ethicon, Inc.
    • Equinox, Inc.
    • Johnson & Johnson Services, Inc.
    • Kellogg Company
    • Life Time Fitness Inc.
    • Medtronic
    • NutriSystem, Inc.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product & Services
      • Market Snippet, By Age Group
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Restraints
    • Market Opportunities
    • Regulatory Scenario
    • Industry Trend
    • Merger and Acquisitions
    • New Product Approvals/Launch
    • PEST Analysis
  4. Global Weight Loss and Obesity Management Market, By Product & Services, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Bupropion-naltrexone (Contrave)
        • Liraglutide (Saxenda)
        • Lorcaserin (Belviq)
        • Orlistat (Xenical)
        • Phentermine-topiramate (Qsymia)
        • Others
    • Supplements
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Equipment
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Fitness Equipment
        • Surgical Equipment
    • Services
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Consulting Service
        • Online Weight Loss Programs
        • Others
  5. Global Weight Loss and Obesity Management Market, By Age Group, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Children
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Adults
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Geriatrics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Weight Loss and Obesity Management Market, By Region, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Product & Services, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product & Services, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product & Services, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product & Services, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Product & Services, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product & Services, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  7. Competitive Landscape
    • Heat Map Analysis
    • Market Share  Analysis
    • Company Profiles
      • Novo Nordisk A/S
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Takeda Pharmaceutical Company Ltd
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Eisai Co., Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • F. Hoffmann-La Roche Ltd
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      •   VIVUS Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Herbalife Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Apollo Endosurgery (U.S.)
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Amer Sports
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Brunswick Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies  
      • Cybex International
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Ethicon, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies  
      • Equinox, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Johnson & Johnson Services, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Kellogg Company
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Life Time Fitness Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Medtronic
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • NutriSystem, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 32 market data tables and 28 figures on “Weight Loss and Obesity Management Market - Global forecast to 2027”.